Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ABOSABOS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ACUMEN PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 183,927 shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $491,085 as of 2026-Q2. The position was decreased (-11.0% shares).

Current Value

$491,085

Current Shares

183,927

Total Value Change

+$114,157

Total Shares Change

-35,217

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
183,927
-11.0%
$491,0850.0%$2.67
0
2026-Q1
Increased
206,683
+75.4%
$487,7720.0%$3.31
36
2025-Q4
Decreased
117,851
-19.9%
$248,6660.0%$2.00
0
2025-Q3
Decreased
147,148
-56.0%
$251,6230.0%$1.58
0
2025-Q2
Increased
334,683
+70.6%
$388,2320.0%$1.12
35
2025-Q1
Decreased
196,207
-10.5%
$215,8280.0%$1.19
0
2024-Q4
New
219,144
-
$376,9280.0%$1.75
33

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used